DeFloria Advancing Charlotte's Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug
DeFloria Advancing Charlotte's Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug
Pilot Program Expands Access to Science-Backed CBD for Senior Cancer Patients through Healthcare Insurance Coverage
Healthcare Focus, Product Innovation, and Cost Improvements
Healthcare Focus, Product Innovation, and Cost Improvements
Accomplished Executive Brings Three Decades of Transformation and Financial Leadership Experience from Global Consumer Goods and Financial Services Industries
Accomplished Executive Brings Three Decades of Transformation and Financial Leadership Experience from Global Consumer Goods and Financial Services Industries
Charlotte’s Web Holdings received a Buy rating and price target from Zuanic and Associates analyst Pablo Zuanic today. The company’s shares opened today at $0.18.Elevate Your Investing Strategy: Take...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...
The fourth addition to its hemp-derived THC product lineup, Knockout expands Charlotte's Web's Brightside collection into the sleep market by combining cannabinoids, clean ingredients, and fast-acting...